Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Therapeutic Research, Clinical and Experimental|October 14, 2021
Improving Risk Assessment in Clinical Trials: Toward a Systematic Risk-Based Monitoring ApproachFiras Fneish, Frank Schaarschmidt, Gerhard Fortwengel
Current Therapeutic Research, Clinical and Experimental|January 3, 2022
Patient Benefit of Clinical Research in Diversely Advanced African Developing CountriesVanessa Strüver, Sheraz Ali, Firas Fneish, et al.
Pharmaceutical Statistics|October 30, 2024
Prediction Intervals for Overdispersed Poisson Data and Their Application in Medical and Pre-Clinical Quality ControlMax Menssen, Martina Dammann, Firas Fneish, et al.
Therapeutic Innovation & Regulatory Science|July 14, 2023
Application of Statistical Methods for Central Statistical Monitoring and Implementations on the German Multiple Sclerosis RegistryFiras Fneish, David Ellenberger, Niklas Frahm, et al.
Saudi Journal of Biological Sciences|December 6, 2021
Piper crocatum Ruiz & Pav. ameliorates wound healing through p53, E-cadherin and SOD1 pathways on wounded hyperglycemia fibroblastsAndina Setyawati, Mae Sri Hartati Wahyuningsih, Dwi Aris Agung Nugrahaningsih, et al.
Frontiers in Neurology|October 5, 2020
Management of MS Patients Treated With Daclizumab - a Case Series of 267 PatientsPaulus S Rommer, Klaus Berger, David Ellenberger, et al.
Gene|June 9, 2024
Birch pollen-induced signatures in dendritic cells are maintained upon additional cytomegalovirus exposureZeinab Fneish, Jennifer Becker, Felix Mulenge, et al.
Multiple Sclerosis and Related Disorders|October 8, 2021
Characteristics of secondary progressive multiple sclerosis: Disease activity and provision of care in Germany - A registry-based/multicentric cohort studyNiklas Frahm, David Ellenberger, Firas Fneish, et al.
Therapeutic Advances in Neurological Disorders|March 18, 2024
Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populationsAlexander Stahmann, Elaine Craig, David Ellenberger, et al.
Acta Neuropathologica Communications|June 18, 2026
Higher disease reactivation risk in women after fingolimod withdrawalMarine Massy, Stefanie Marti, Adriane Kutllovci, et al.
Pageof 2